A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone
Clinical trial NCT02288247 · COMPLETED
Trial details
- NCT number
- NCT02288247
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-04-30
- Enrollment
- 688
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.